Omega Pharma Completes Acquisition of Inpha 2000 with PedersoliGattai

Deal News | Dec 18, 2024 | PedersoliGattai

Omega Pharma, a leader in the nutraceutical market, has successfully completed the acquisition of Inpha 2000, an Italian company known for its high scientific rationale in the research, development, and commercialization of nutraceuticals. PedersoliGattai assisted Omega Pharma in this transaction, with a comprehensive legal team addressing various aspects such as finance, antitrust, and due diligence. The legal advisors included multiple specialists from the firm, ensuring a smooth acquisition process for Omega Pharma.

Sectors

  • Nutraceuticals
  • Legal Services

Geography

  • Italy – Inpha 2000 is based in Italy, and the acquisition involves the Italian market, making Geography relevant in terms of regulatory and market conditions.

Industry

  • Nutraceuticals – The article centers around Omega Pharma's acquisition of Inpha 2000, a company involved in the research, development, and commercialization of nutraceuticals.
  • Legal Services – PedersoliGattai provided legal services for Omega Pharma's acquisition of Inpha 2000, handling diverse aspects including finance and antitrust.

Financials

    Participants

    NameRoleTypeDescription
    Omega PharmaBidding CompanyCompanyOmega Pharma is a leader in the nutraceutical market, now expanding its presence with the acquisition of Inpha 2000.
    Inpha 2000Target CompanyCompanyInpha 2000 is an Italian company specializing in the research, development, and commercialization of scientifically-backed nutraceuticals.
    PedersoliGattaiLegal AdvisorCompanyPedersoliGattai provided comprehensive legal assistance to Omega Pharma in the acquisition of Inpha 2000.
    Stefano CatenacciLegal AdvisorPersonPartner at PedersoliGattai, led the legal team assisting Omega Pharma.
    Tomaso MorinoLegal AdvisorPersonAssociate at PedersoliGattai, a member of the team assisting Omega Pharma.
    Francesca ZulianiLegal AdvisorPersonAssociate at PedersoliGattai, a member of the team assisting Omega Pharma.
    Gian Luca CoggiolaFinance AdvisorPersonPartner at PedersoliGattai, handled the finance aspects of the acquisition.
    Cesare GuglielminiFinance AdvisorPersonAssociate at PedersoliGattai, assisted with the finance aspects of the acquisition.
    Fabiana CampopianoAntitrust AdvisorPersonSenior Counsel at PedersoliGattai, managed the antitrust considerations for the acquisition.
    Letizia SartoriAntitrust AdvisorPersonAssociate at PedersoliGattai, assisted with antitrust considerations.
    Arianna CornoAntitrust AdvisorPersonAssociate at PedersoliGattai, assisted with antitrust considerations.
    Nicola MarteganiDue Diligence AdvisorPersonSenior Counsel at PedersoliGattai, led the due diligence team.
    Matteo BortolottiDue Diligence AdvisorPersonSenior Associate at PedersoliGattai, part of the due diligence team.
    Martina MoroniDue Diligence AdvisorPersonAssociate at PedersoliGattai, part of the due diligence team.